Stock Market News

CRISPR (CRSP) Rated Overweight on Gene Editing Growth

wcc wcc
Mar 31, 2026 - 10:10
0 2
CRISPR (CRSP) Rated Overweight on Gene Editing Growth
Previous Article

Canaccord Maintains Hold on Joby (JOBY) Amid Flight Testing Milestones

Next Article

Rocket Lab (RKLB) Rated Buy on $190M Defense Contract

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Wow Wow 0
Sad Sad 0
Angry Angry 0
wcc
wcc

Related Posts

The Retirement Income Bet That Takes 12 Years To Pay Off

The Retirement Income Bet That Takes 12 Years To Pay...

wcc
Jun 25, 2026
0
0
Market Update: PAYX, LDOS, UTHR, UAL

Market Update: PAYX, LDOS, UTHR, UAL

wcc
Jun 25, 2026
0
0
Why a $700 Dell Stock Price Isn’t as Crazy as It Sounds

Why a $700 Dell Stock Price Isn’t as Crazy as It Sounds

wcc
Jun 25, 2026
0
0
Retirees face a new challenge: How to spend their 401(k) savings

Retirees face a new challenge: How to spend their 40...

wcc
Jun 25, 2026
0
0
Edward Jones Offers Carefull Fraud Protection Free to Clients

Edward Jones Offers Carefull Fraud Protection Free t...

wcc
Jun 25, 2026
0
0
The Vanguard ETF That Could Set You Up for Life if You Buy It Today

The Vanguard ETF That Could Set You Up for Life if Y...

wcc
Jun 25, 2026
0
0

Comments (0)

User